OR WAIT null SECS
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
The European Commission has purchased an additional 150 million doses of Moderna’s COVID-19 vaccine for delivery in 2022.
The European Commission (EC) has purchased an additional 150 million doses of Moderna’s COVID-19 vaccine for delivery in 2022. The new contract was announced by Moderna in a June 22, 2021 press release.
With this additional order, the total number of doses now confirmed and purchased by the EC has reached 460 million. Under the terms of the agreement, the additional doses, which will enable European countries to access the updated COVID-19 vaccine booster candidates, will begin to be delivered in 2022. However, the purchase is still subject to regulatory approval of the booster vaccine candidates by the European Medicines Agency (EMA).
“We appreciate the collaboration with the EC for these additional doses of the Moderna COVID-19 vaccine, which could be used for primary vaccination, including of children, or possibly as a booster if that becomes necessary to continue to defeat the pandemic,” said Stephane Bancel, Moderna’s CEO, in the press release. “We are encouraged by the initial booster data, which reinforce our confidence that our booster strategy should be protective against current variants. We will remain proactive as the virus evolves by leveraging the flexibility of our mRNA platform to stay ahead of emerging variants.”